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Abstract
The purpose of this literature review is to evaluate current evidence regarding elevated
pre-operative hemoglobin A1c levels and its potential effect on post-operative infection risk.
This case report discussion is a result of completion of an Objective Structured Clinical
Examination (OSCE) for a patient who presented for a preoperative total knee arthroplasty
(TKA) evaluation. Research for this literature review was conducted using CINAHL, Pubmed,
and Google Scholar. Keywords used during this search included “elevated hemoglobin A1c and
post-operative infection”. Publication dates were limited between 2015 and 2020. A total of 10
research articles were collected and utilized for this review. The literature that was examined
revealed conflicting evidence that chronic uncontrolled preoperative hyperglycemia, defined as a
hemoglobin A1c greater than 8, is associated with poor post-surgical outcomes including
increased risk for surgical site infection, postoperative wounds, and longer hospital stays.
Background
Type 2 diabetes mellitus is a disease caused by insulin resistance in which cells within
the body no longer respond to insulin. Individuals at risk for type 2 diabetes include those that
are overweight, over the age of 45, have a family history, poor physical activity, and those of
African American, Hispanic, American Indian or Alaska Native background. Type 2 diabetes
can be prevented by appropriate lifestyle changes leading to weight loss reduction through diet
and exercise (“Type 2 Diabetes”, 2019). According to the Centers for Disease Control (CDC),
the incidence of type 2 diabetes mellitus is rapidly growing and affects more than 90-95% of
over 34 million people in the United States that have been diagnosed with diabetes (“Type 2
Diabetes”, 2019).
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Individuals with diabetes mellitus are “more likely to require surgery than a person
without and this is particularly notable for orthopedic surgery” (Akiboye & Rayman, 2017, p.
12). It is estimated that by 2030, in the United States there will be over 4 million joint
arthroplasties performed with 8% of these patients having diabetes mellitus (Yang, Sun, Li, &
Liu, 2017). Diabetes mellitus is a known risk factor for poor postoperative outcomes. Patients
with diabetes have a 50% higher risk of postsurgical site infection compared to patients without
diabetes (McCall, 2015). According to Han and Kang (2013), hyperglycemia causes impaired
phagocytosis and delayed collagen synthesis, thus leading to poor wound healing and increased
risk of infection. Additionally, anesthesia and surgery can lead to a stress response that releases
various hormones throughout the body, such as cortisol and glucagon, causing increased insulin
resistance and elevated glucose levels (Akiboye & Rayman, 2017).
The success of diabetic treatment can be monitored through hemoglobin A1c testing.
Hemoglobin A1c is a blood test that is a marker for average blood glucose levels over the
previous two to three months (Finger, et al., 2017). A diagnosis of type 2 diabetes can be made
by a hemoglobin A1c greater than 6.5%. According to the American Diabetes Association
(ADA), for individuals with diabetes the goal hemoglobin A1c is below 7% (“Understanding
A1C”, n.d.). For surgery, the ADA, Endocrine Society, and the American Association of Clinical
Endocrinologists (AACE) recommend a peri-operative glucose less that 140mg/dL and a random
blood glucose less than 180mg/dL (Akiboye & Rayman, 2017).
In this case report, the patient was seen for a preoperative evaluation and was scheduled
for a right TKA. She had a diagnosis of controlled type 2 diabetes mellitus with a recent
hemoglobin A1c level of 8.1 that had been trending upward in comparison to prior visits. She
recently was non-compliant with her prescription for Victoza, a glucagon-like peptide-1 receptor
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medication for her type 2 diabetes mellitus. During this visit, her elevated hemoglobin A1c was
addressed and concerns for an increased risk of postsurgical infection was discussed. This
literature review will explore evidence-based research concerning elevated pre-operative
hemoglobin A1c and its potential effect on post-operative infection risk.
Case Report
Chief Complaint: Preoperative exam
HPI: Eileen is a pleasant 57-year-old female who presents to the office today for a preoperative
consultation at the requirement of Dr. Piatt who plans on performing a right knee arthroplasty
under general anesthesia on 3/4/20. This will be an outpatient procedure.
Past medical history:
Allergies: Amlodipine Besylate (Rash), Cats (Watery eyes, difficult breathing), Environmental
allergens (Hayfever)
Medications:
1. Diclofenac sodium 75 mg delayed-release (enteric coated) tablet. Take 1 tablet (75 mg)
by mouth 2 times a day 60 tablet.
2. Fluticasone 50 mcg/spray nasal spray. Spray 1 spray into each nostril 1 time per day 16 g.
3. Metformin 500 mg extended release tablet. Take 4 tablets by mouth per day.
4. Acetaminophen 400 mg tablet. Take 1,000 mg by mouth every 4 hours as needed.
5. Vitamin C 500 MG tablet. Take 1,000 mg by mouth 1 time per day.
6. Milk thistle-Tumeric capsule. Take 1 capsule by mouth 1 time per day.
7. Glipizide ER 10 mg extended release tablet (24 hr). Take 1 tablet (10 mg) by mouth 1
time per day.
8. Hydrochlorothiazide 25 mg tablet. Take 1 tablet (25 mg) by mouth 1 time per day.
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9. Lovastatin 10 mg tablet. Take 1 tablet (10 mg) by mouth 1 time per day.
10. Benazepril 40 mg tablet. Take 1 tablet (40 mg) by mouth 1 time per day.
11. Multiple Vitamins-Minerals. Take 1 tablet by mouth 1 time per day.
12. Echinacea C Complete. Take 1 tablet by mouth 1 time per day.
13. Cinnamon. Take 1 capsule by mouth 1 time per day.
Medical:
1. Primary osteoarthritis of both knees
2. Controlled type 2 diabetes mellitus without complication, without long-term current use
of insulin
3. CKD (chronic kidney disease), stage III
4. Hypercholesterolemia
5. Essential hypertension
6. Neuroma of foot
7. Obstructive sleep apnea of adult
8. Severe obesity
9. Hypomagnesemia
Surgical:
1. Left total knee arthroplasty
Family History: Her father had emphysema and her mother had diabetes. Her five siblings
otherwise have a negative medical history.
Social History: She is married with two children and currently works at Explore MN tourism.
She has never smoked or used tobacco. She currently has two alcoholic beverages per week. She
has no history of drug use.
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ROS
General: Denies fever, chills, night sweats, weight loss/gain or loss of appetite.
HEENT: Denies blurry vision, dysphagia, sore throat or congestion.
Neck: Denies stiffness or pain.
Respiratory: Denies wheezing, cough, and SOB.
Cardiovascular: Denies chest pain, tightness, palpitations, or edema.
Gastrointestinal: Denies nausea, vomiting, diarrhea, constipation, melena, hematochezia, or
GERD.
Genitourinary: Denies incontinence, hematuria, dysuria, frequency, or urgency.
Musculoskeletal: Denies myalgias, arthralgias, or swollen joints.
Neurologic: Denies headaches, numbness, or weakness.
Lymph: Denies lymphadenopathy.
Hematology: Denies any bleeding or clotting disorders.
Psychiatric: Denies anxiety or depression.
Physical Examination
Vitals: BP: 136/90 P: 88
Weight: 168.3 kg (371 lb)
Body mass index is 53.23 kg/m².
General: The patient is a pleasant. No acute distress.
HEENT: Pupils equally round and reactive to light. Extraocular muscles are intact. Conjunctivae
clear. Tympanic membranes normal with no erythema or bulging. No nasal edema or rhinitis.
Good dentition with no loose teeth. Uvula midline. Pharynx with no erythema or exudate.
Neck: Trachea midline. Neck supple. No thyromegaly or thyroid nodules.
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No supraclavicular or cervical lymphadenopathy.
Heart: Normal rate, regular rhythm, S1 normal, S2 normal and normal heart sounds.
Lungs: Clear to auscultation bilaterally with no wheezes or crackles. Effort normal and breath
sounds normal.
Abdomen: Soft, nontender, nondistended. No hepatosplenomegaly. No rebound tenderness or
guarding.
Musculoskeletal: Muscle strength is 5 out of 5 of the upper and lower extremities bilaterally.
Neurological: Cranial nerves II through XII are intact with gross examination. Deep tendon
reflexes 2+ bilaterally to bicep, tricep, brachioradialis and patellar reflexes.
Skin: Skin is warm and dry. No abnormal lesions or rashes present.
Psychological: Normal concentration. No active depression or anxiety.
Labs/Diagnostics
1. Glucose 229, BUN 21, Creatinine 1.57, otherwise CMP unremarkable
2. CBC normal
3. Hemoglobin A1c 8.1
4. Magnesium normal
5. EKG normal sinus rhythm
Surgical risk
Surgical risk: Intermediate
History blood clotting or bleeding disorders: No
Has tolerated anesthesia in the past: Yes
Postoperative nausea: No
Pain, stiffness, arthritis of the neck: No
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Preoperative risk assessment includes:
1. Cardiovascular status.
Patient has had no history of ischemia, MI, dysrhythmias, angina or cardiomyopathy. Does have
history of HTN and HLD, which is controlled on medication. Her exam is unremarkable.
EKG: Unremarkable
ACC/AHA Cardiac Risk Factors:
History of ischemic heart disease: No
History of compensated or prior heart failure: No
History of cerebrovascular disease: No
Diabetes mellitus: Yes
Renal insufﬁciency >2: No
Functional Capacity:
Some shortness of breath when climbing two flights of stairs. No chest pain.
2. Pulmonary status.
Tobacco user: No
BMI: 53%
Patient does have a history of sleep apnea and is currently not wearing recommended CPAP at
night. She has had a previous sleep study. Patient has history of asthma that is well controlled
without medications. Patient has no history of COPD or other significant cardiorespiratory
illness. No additional pulmonary assessment indicated.
3. General Risk/Nutrition
Gerd: No
Obesity: Yes
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Anemia: Yes
Hearing impaired/hearing aids: Yes
Dentures: No
Dysphagia: No
3. Infectious risk.
Patient has no evidence of upper or lower respiratory infection, skin infection, or urinary tract
infection. However, I do have concerns regarding healing and risk for infection post-surgery due
to uncontrolled DM. MRSA screen: negative.
4. Cognitive status.
Patient has no history of excessive alcohol use, alcohol withdrawal symptoms, or drug use. She
has no history of contraindications to use of post-operative pain medications or narcotic
analgesics as needed.
Assessment
1. Primary osteoarthritis of both knees
2. Uncontrolled Type II diabetes
3. CKD (chronic kidney disease), stage III
4. Essential Hypertension
5. Hypercholesteremia
6. Obstructive Sleep Apnea
7. Severe Obesity, BMI 53%
Plan: I discussed with patient that I do not recommend proceeding with her surgery until she has
better control of her blood sugars as poor blood sugar control is linked with decreased wound
healing and increased risk of infection after surgery. I will consult with her surgeon regarding my
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concerns. Keep taking oral diabetic medications. I recommend she start taking Rybelsus once
daily to help improve glycemic control. Will re-check A1c in 3 months. I would also like her to
see the diabetic educator. Her kidney function has steadily declined. Stop all NSAIDS to protect
kidneys. Referral for nephrology. Blood pressures have been well controlled. Continue
medications as prescribed. Continue medications as prescribed for hypercholesteremia. We
discussed importance of wearing CPAP at night. We discussed diet modifications. Once blood
sugars have improved, surgery should help increase exercise which will also help with weight
management.
Literature Review
For diabetic patients undergoing TKA, poor preoperative glycemic control, including a
hemoglobin A1c greater than 8%, has been linked with a higher risk of postoperative wound
infections. A retrospective study conducted by Han and Kang (2013), explored 115 patients with
type 2 diabetes mellitus who underwent a TKA and discovered that the risk of postoperative
wound infection was correlated with a hemoglobin A1c greater than 8%. While the association
may not be significant, overall 6.6% of the patients in their study had wound complications.
They also found that not only was preoperative glycemic control important to decreasing the risk
of wound infection, operative time was also a factor to be considered. This study suggested that
surgeons should exercise caution when selecting patients, as well as consider operative time as a
risk factor for poor outcomes.
Cancienne, Werner, & Browne (2017) additionally found that as perioperative
hemoglobin A1c increases, so does the risk of postoperative deep infection requiring surgical
intervention after TKA. In their cohort study, patients who had a hemoglobin A1c greater than
8% were more likely to develop an infection within one year after their TKA than those whose
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hemoglobin A1c levels were less than 8%. While elevated hemoglobin A1c was associated with
deep postoperative infection after TKA, they did conclude that hemoglobin A1c could not be
used as an isolated predictor for post-operative infection due to poor sensitivity and intermediate
specificity. Because of this finding, it is recommended that hemoglobin A1c be considered as a
reference when assessing risk factors for infection prior to surgery along with other potential risk
factors (Cancienne, Werner, & Browne, 2017).
While multiple studies have been outlined that support an elevated hemoglobin A1c
greater than 8% in diabetic patients undergoing a TKA with an increased risk of post-surgical
infection, a meta-analysis conducted by Yang, Sun, Li, & Liu (2017) did not find a specific
optimal threshold for hemoglobin A1c and increased post-surgical joint infection risk. However,
their meta-analysis of 6 retrospective studies did demonstrate that there was a significantly
higher risk of periprosthetic joint infections in association to hemoglobin A1c levels, thus
warranting the screening of hemoglobin A1c to assess deep infection risk prior to surgery.
Multiple studies outside of TKA procedures have also suggested increased post-operative
infectious risk in diabetic patients. A prospective, observational pilot study by Chen et al. (2018)
followed noncardiac surgical patients for one week after their procedure. During the first 7 days
after surgery, 9 patients with a A1c greater than 7% developed infections including urinary tract
infections, surgical wound infections, or hospital-acquired pneumonia (Chen, et al., 2018).
Additionally, they found that patients with a hemoglobin A1c greater than 7% had significantly
higher variability with their postoperative glucose levels, making postoperative glycemic control
difficult. Preoperative hemoglobin A1c levels greater than 7% have also been linked with higher
rates of surgical site infections for individuals undergoing lumbar spinal instrumentation and
thoracic surgery. Additionally, hemoglobin A1c levels higher than 7% also carry an increased
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risk of mortality in patients undergoing primary joint arthroplasty (Akiboye & Rayman, 2017).
Finger et al. (2017) discovered a correlation of increased postoperative infection risk, including
sepsis, urinary tract infections, and pneumonia, along with increased hospital stay among
patients undergoing cardiac surgical procedures with a hemoglobin A1c greater than 7%.
Considering these findings, it is suggested that glycemic control should be optimized before
scheduling elective surgeries for patients (Chen, et al., 2018).
One interesting aspect to consider is how hemoglobin A1c screening prior to surgery
allows for closer monitoring during the perioperative and postoperative period. Jones et al.
(2014) discuss how elevated hemoglobin A1c before gastrointestinal surgery can help to identify
patients that are at a higher risk of post-operative hyperglycemia. Post-operative hyperglycemia
can lead to complications such as increased post-operative infections, increased length of stay,
and increased mortality among patients. In their observational cohort study, post-operative
hyperglycemia was linked with hospital readmission, but elevated pre-operative hemoglobin A1c
was not. They suggest this is the result of the ability of providers to identify these increased risk
factors through hemoglobin A1c screening prior to gastrointestinal surgery. This led to closer
glucose monitoring and insulin use post-operatively which decreased infection rates and
improved outcomes. Glycemic control post-operative was identified as keeping the patient’s
glucose levels under 250mg/dL as patients with glucose levels greater than 250mg/dL were 20%
more likely to be readmitted (Jones, et al., 2014).
Lack of post-operative glycemic control has also been found to increase infectious
complications in a retrospective study completed by Reátegui et al. (2014). While preoperative
hemoglobin A1c has been the focus of this case report, it is important to outline the significance
of post-operative glycemic control and its effect on infectious risk. Both diabetic and non-

HEMOGLOBIN A1C AND POST-SURGICAL INFECTIONS

14

diabetic patients undergoing TKA were examined in their retrospective study and a high rate of
post-operative complications were found in patients one year after their TKA. Those postoperative complications included urinary tract infections, wound infection, prosthetic infection,
phlebitis, and sepsis. Infections were discovered in 11.3% of the 833 patients studied (Reátegui,
et al., 2014). Despite what other studies have found, in their study they did not find a correlation
between diabetes mellitus and complications. Rather they discovered that stress-induced
hyperglycemia as a result of the surgical process led to increased infections regardless of a
diabetes mellitus diagnosis. Overall, their study concluded that proper post-operative glycemic
control for all patients, despite a diagnosis of diabetes mellitus, is imperative to reducing postoperative infections. Contrary to their findings, Finger et al. (2017) determined that while
hyperglycemia perioperatively was associated with postoperative infections, chronic elevated
hemoglobin A1c was also a risk factor for postsurgical infections, even with tight perioperative
glycemic control.
A retrospective study performed by Underwood et al. (2014) revealed that of all of the
diabetic patients enrolled, 65% of them did not have a recent A1c measurement within the
previous 3 months available. This is an area of concern for diabetic patients going into surgery
because of the known increase risk of poor outcomes and suggests that inadequate glycemic
control may be occurring during the perioperative period. Due to lack of data, anesthesiologists,
surgeons, endocrinologists, and internists are using subjective A1c guidelines with some
surgeons using the ADA recommendation of a hemoglobin A1c less than 7% before performing
elective surgeries (Underwood, et al., 2014). Underwood et al. (2014) suggest that algorithms
should be utilized by surgeons and anesthesiologists to help improve glycemic control for
patients with a hemoglobin A1c greater than 8% so that those individuals that are considered
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high risk are more easily identified and appropriately treated throughout the preoperative and
perioperative period.
Additional risk factors have been identified as an important component for the surgeon to
consider prior to surgery. Blankush et al., (2016) propose age, wound classification, and surgical
risk classification as strong indicators of post-surgical infection risk in addition to hemoglobin
A1c. In their retrospective study, they revealed that elevated pre-operative A1c greater than 7%
was not an adequate solo indicator of infectious risk post-surgery. However, they did discover
that hemoglobin A1c did have predictive value for post-operative infection risk when applied to
certain subgroups within their study. Patients with a preoperative hemoglobin A1c greater than
8% and a dirty wound had a higher risk for post-operative infection. Also, patients older than 81
years of age, regardless of wound classification, with a pre-operative hemoglobin A1c greater
than 7.5% were more likely to suffer a post-operative infection with rates being as high as 1 in 4
(Blankush, et al., 2016). This study was interesting as it suggested post-operative infection risks
as complex, with subgroups being affected differently based on the combination of both elevated
pre-operative hemoglobin A1c levels and other risk factors. Akiboye & Rayman (2017) further
recommend considering co-morbid conditions, especially for orthopedic surgeries, when
assessing post-surgical infection risk. Co-morbid conditions include hypertension, obesity, sleep
apnea, and vascular changes associated with diabetes mellitus. By identifying these risk factors,
surgeons can more readily assess which subgroups may be at higher risk of post-operative
infection and may optimize medications and hyperglycemia prior to surgery to improve
outcomes.
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Learning Points
•

For diabetic patients undergoing TKA, poor preoperative glycemic control, including a
hemoglobin A1c greater than 8%, is linked with a higher risk of postoperative wound
infections.

•

Checking a hemoglobin A1c prior to surgery can allow for closer monitoring of
hyperglycemia in diabetic patients during the preoperative and perioperative period,
improving postsurgical outcomes.

•

The pre-operative assessment should include a risk assessment of the diabetic patient,
taking into account their secondary complications due to diabetes and co-morbidities as
this has been correlated with an increased risk of postoperative complications including
infection. Medications and glycemia should also be optimized prior to surgery.

16

HEMOGLOBIN A1C AND POST-SURGICAL INFECTIONS

17

References
Akiboye, F., & Rayman, G. (2017). Management of Hyperglycemia and Diabetes in Orthopedic
Surgery. Current Diabetes Reports, 17(2). doi: 10.1007/s11892-017-0839-6
Blankush, J. M., Leitman, I. M., Soleiman, A., & Tran, T. (2016). Association between elevated
pre-operative glycosylated hemoglobin and post-operative infections after non-emergent
surgery. Annals of Medicine and Surgery, 10, 77–82. doi: 10.1016/j.amsu.2016.07.025
Cancienne, J. M., Werner, B. C., & Browne, J. A. (2017). Is There an Association Between
Hemoglobin A1C and Deep Postoperative Infection After TKA? Clinical Orthopaedics
and Related Research®, 475(6), 1642–1649. doi: 10.1007/s11999-017-5246-4
Chen, P., Hallock, K. K., Mulvey, C. L., Berg, A. S., & Cherian, V. T. (2017). The Effect of
Elevated A1C on Immediate Postoperative Complications: A Prospective Observational
Study. Clinical Diabetes, 36(2), 128–132. doi: 10.2337/cd17-0081
Finger, B., Brase, J., He, J., Gibson, W. J., Wirtz, K., & Flynn, B. C. (2017). Elevated
Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased
Postoperative Infections and Longer Hospital Stay After Cardiac
Surgical Procedures. The Annals of Thoracic Surgery, 103(1), 145–151. doi:
10.1016/j.athoracsur.2016.05.092
Han, H.-S., & Kang, S.-B. (2013). Relations between Long-term Glycemic Control and
Postoperative Wound and Infectious Complications after Total Knee Arthroplasty in
Type 2 Diabetics. Clinics in Orthopedic Surgery, 5(2), 118. doi:
10.4055/cios.2013.5.2.118
Jones, C. E., Graham, L. A., Richman, J., Hollis, R. H., Wahl, T. S., Copeland, L. A., … Hawn,
M. T. (2016). Association Between Preoperative Hemoglobin A1c, Postoperative
Hyperglycemia, and Readmissions after Gastrointestinal Surgery. Journal of the

HEMOGLOBIN A1C AND POST-SURGICAL INFECTIONS

18

American College of Surgeons, 223(4). doi: 10.1016/j.jamcollsurg.2016.06.220
McCall, B. (2015, December 31). Diabetes a Big Risk Factor for Surgical Site Infections.
Retrieved March 24, 2020, from https://www.medscape.com/viewarticle/856619
Reátegui, D., Sanchez-Etayo, G., Núñez, E., Tió, M., Popescu, D., Núñez, M., & Lozano, L.
(2014). Perioperative hyperglycaemia and incidence of post-operative complications in
patients undergoing total knee arthroplasty. Knee Surgery, Sports Traumatology,
Arthroscopy, 23(7), 2026–2031. doi: 10.1007/s00167-014-2907-7
Type 2 Diabetes. (2019, May 30). Retrieved March 24, 2020, from
https://www.cdc.gov/diabetes/basics/type2.html
Understanding A1C. (n.d.). Retrieved March 27, 2020, from https://www.diabetes.org/a1c
Underwood, P., Askari, R., Hurwitz, S., Chamarthi, B., & Garg, R. (2014). Preoperative A1C
and Clinical Outcomes in Patients With Diabetes Undergoing Major Noncardiac Surgical
Procedures. Diabetes Care, 37(3), 611–616. doi: 10.2337/dc13-1929
Yang, L., Sun, Y., Li, G., & Liu, J. (2017). Is hemoglobin A1c and perioperative hyperglycemia
predictive of periprosthetic joint infection following total joint
arthroplasty? Medicine, 96(51). doi: 10.1097/md.0000000000008805

